Live Status Check

NCT07432295 Recruiting Status

Real-time enrollment status for this solid tumor clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 4:17 PM UTC

NCT07432295 Status Summary

NCT NumberNCT07432295
Recruiting StatusRecruiting
ConditionSolid Tumor
PhaseClinical Trial
Target Enrollment180 participants
Active Locations3 sites in the US
SponsorI-Mab Biopharma US Limited
Last Updated on CT.govMay 14, 2026 (May 14, 2026)

About NCT07432295 Enrollment Status

As of July 13, 2026: Clinical trial NCT07432295 is currently recruiting participants. This clinical trial study for solid tumor is actively seeking new participants at 3 locations across the United States. The study is sponsored by I-Mab Biopharma US Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT07432295

Is NCT07432295 still recruiting?

Yes, NCT07432295 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT07432295 recruiting?

This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT07432295?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT07432295 status last updated?

The official ClinicalTrials.gov record for NCT07432295 was last updated May 14, 2026 (May 14, 2026). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial